CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NBIX — Neurocrine Biosciences Inc
CIK 884546
SAN FRANCISCO, CA
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$164,204,982
+$45,271,691 QoQ
Shares Held
974,279
+7.9% QoQ
Ownership
0.958%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#17
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $1,705,244,386 across 43 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,003,981 | $287,726,073 | |
| 2 | VTRS |
Viatris Inc
|
13,567,342 | $215,449,390 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
974,279 | $164,204,982 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
297,162 | $161,011,285 | |
| 5 | ALKS |
Alkermes plc.
|
2,335,117 | $122,360,130 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,553,213 | $87,444,571 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
2,453,787 | $85,072,795 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
665,457 | $73,825,799 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,204,982 | 974,279 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $118,933,291 | 902,788 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $120,645,136 | 850,632 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $116,451,807 | 829,547 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $99,259,278 | 789,715 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $85,800,493 | 775,773 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $104,089,030 | 762,557 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $86,102,869 | 747,291 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $103,596,812 | 752,501 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $100,016,549 | 725,178 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $90,497,379 | 686,835 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $70,117,537 | 623,267 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $57,045,181 | 604,933 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $59,152,158 | 584,392 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $67,607,698 | 566,039 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $57,457,060 | 540,976 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $51,956,937 | 533,001 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $48,829,593 | 520,849 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $43,403,909 | 509,615 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $47,673,791 | 497,068 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $46,679,440 | 479,649 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $45,422,557 | 467,070 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,482,837 | 474,521 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $45,246,357 | 470,532 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $56,422,804 | 462,482 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $39,123,109 | 452,029 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||